Infusions, Parenteral: Clinical Trials

10 trials of Infusions, Parenteral, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 unknown, 1 recruiting, 1 suspended. 5 Phase 2, 4 Not applicable, 3 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 25Completed 2, Suspended 1, Terminated 1, Unknown 1
Not applicable4Completed 2, Recruiting 1, Unknown 1
Phase 13Completed 1, Terminated 1, Unknown 1
Phase 31Completed 1

Follow Infusions, Parenteral: new trials by email Literature Review of Infusions, Parenteral trials Research Report on Infusions, Parenteral

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Intraperitoneal Dexmedetomidine Added to Bupivacaine 0.25% Versus Bupivacaine Alone on Postoperative Analgesia in Patients Undergoing Laparoscopic Cholecystectomy
Bupivacaine 0.25% intraperitoneal, Bupivacaine 0.25% + Dexmedetomidine 0.5 µg/kg intraperitoneal - Postoperative Pain Management, Cholelithiasis
Not applicableCompletedAin Shams University302025-03-022026-02-05
DDP ip Combined With AG in PDAC With Peritoneal Metastasis
intraperitoneal (IP) Cisplatin combined with intravenous gemcitabine + nab-paclitaxel - Pancreatic Neoplasm
Phase 2CompletedFudan University912022-05-152025-05-22
Comparison of Ultrasound-Guided Quadratus Lumborum Plane Block Versus Intraperitoneal and Periportal Bupivacaine Infiltration in Postoperative Analgesia After Laparoscopic Cholecystectomy
Bilateral QL block, Intraperitoneal and port sites infiltration - Quadratus Lumborum, Laparoscopic Cholecystectomy
Not applicableCompletedmedina medical center702022-04-032024-12-06
GORE® ENFORM Biomaterial Product Study
Gore ENFORM Biomaterial (Preperitoneal), Gore ENFORM Biomaterial (Intraperitoneal) - Hernia, Ventral, Hernia, Hiatal
Not applicableRecruitingW.L.Gore & Associates2452021-05-172026-07-30
Tolerance of Intraperitoneal (IP) Nivolumab After Extensive Debulking Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Ovarian Carcinoma
Intraperitoneal (IP) nivolumab infusion - Ovarian Cancer
Phase 1 / Phase 2CompletedHospices Civils de Lyon222019-10-172025-12-19
Safety of Intraperitoneal (IP) OXAliplatin (OXA) in Association With Systemic FOLFIRI Bevacizumab Chemotherapy in Patients With Peritoneal Carcinosis
intraperitoneal (IP) OXAliplatin (OXA) + systemic FOLFIRI bevacizumab chemotherapy - Peritoneal Carcinosis
Phase 1 / Phase 2UnknownHospices Civils de Lyon472017-05-182017-09-21
Randomized Controlled Trail for Post Laparoscopic Pain
Combined maneuver, Intraperitoneal infusion - Shoulder Pain
Not applicableUnknownTaipei Veterans General Hospital, Taiwan3602013-04-012016-04-20
Clinical Trial at Neoadjuvant Peritoneal and Systemic Chemotherapy Plus HIPEC in Gastric Carcinomatosis
Intraperitoneal and systemic chemotherapy plus maximum cytoreduction plus HIPEC - Peritoneal Carcinomatosis, Gastric Cancer
Phase 2SuspendedHospital General Universitario Gregorio Marañon502011-01-012016-11-21
Intraperitoneal (IP) Cisplatin Given With Paclitaxel to Treat Epithelial Ovarian Cancer
Intraperitoneal (IP) Cisplatin - Epithelial Ovarian Cancer
Phase 1 / Phase 2TerminatedUniversity Health Network, Toronto92007-02-012024-03-26
Intraperitoneal Versus Extraperitoneal Colostomy
intraperitoneal or extraperitoneal colostomy - Colostomy
Phase 3CompletedMayo Clinic811988-01-012013-11-13

Conditions studied

Abdominal Pain (1)  ·  Carcinoma (1)  ·  Carcinoma, Ovarian Epithelial (1)  ·  Cholelithiasis (1)  ·  Hernia (1)  ·  Hernia, Diaphragmatic (1)  ·  Hernia, Hiatal (1)  ·  Hernia, Ventral (1)  ·  Incisional Hernia (1)  ·  Neoplasms (1)  ·  Ovarian Neoplasms (1)  ·  Pancreatic Neoplasms (1)  ·  Peritoneal Neoplasms (1)  ·  Shoulder Pain (1)  ·  Stomach Neoplasms (1)

Sponsors

Hospices Civils de Lyon (2)  ·  Ain Shams University (1)  ·  Fudan University (1)  ·  Hospital General Universitario Gregorio Marañon (1)  ·  Mayo Clinic (1)  ·  Taipei Veterans General Hospital, Taiwan (1)  ·  University Health Network, Toronto (1)  ·  W.L.Gore & Associates (1)  ·  medina medical center (1)

Countries

Egypt (2)  ·  France (2)  ·  United States (2)  ·  Canada (1)  ·  China (1)  ·  Spain (1)  ·  Taiwan (1)

Top investigators

Benoit You, MD (1)  ·  Helen MacKay, MD (1)  ·  Hsiao Wen Tsai, M.D. (1)  ·  Mariam K Habib, MD (1)  ·  Todd Heniford, MD (1)  ·  Yi Jen Chen, M.D., Ph.D. (1)

Results publications

PMID 17043939, PMID 18448749, PMID 38819408

NIH funding

2009 (1), 2018 (1)